News from teva canada limited A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Apr 02, 2019, 07:30 ET Recognizing the Caregiver-Pharmacist Connection on National Caregiver Day

Teva Canada and Huddol collaborate to offer innovative solutions for Caregivers through the Pharmacy team April 2, 2019 is National Caregiver Day in Canada, where: Unpaid caregivers provide up to 75...


Dec 17, 2018, 14:53 ET VOLUNTARY RECALL - One (1) Lot (150261) of EQUATE™ LENS CARE SYSTEM (DIN 02387638) and EQUATE™ MULTI-PURPOSE SOLUTION (DIN 02291126) Due to a Labelling Error; Distributed by Teva Canada Limited

- Canadian Market Only - TORONTO, Dec. 17, 2018 /CNW/ - Teva Canada Limited, with the knowledge of Health Canada, is initiating a nationwide voluntary Type II recall of one (1) lot (listed above) of...


Sep 10, 2018, 12:10 ET Teva Canada Announces the Launch of a Generic Version of (PR)Abilify®, (PR)Teva-Aripiprazole Tablets for the treatment of Schizophrenia

- Currently Available in Canada - TORONTO, Sept. 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announces that the complete line of PrTeva-Aripiprazole (2...


May 10, 2018, 09:19 ET Teva Canada Announces the Launch of Teva-Cyclosporine® Ophthalmic Emulsion, the First Generic Version of Restasis® in Canada for the Treatment of Dry Eye Disease

- Currently Available in Canada - TORONTO, May 10, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced the launch of Teva-Cyclosporine® ophthalmic...


Mar 22, 2018, 08:00 ET Teva Canada Announces the Launch of <C>ACT Methylphenidate ER® Tablets, a Generic Version of <C>Concerta® for the Treatment of ADHD

- Currently available in Canada - TORONTO, March 22, 2018 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application...


Mar 15, 2016, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Abacavir/Lamivudine Tablets, a Generic of (Pr)Kivexa®

TORONTO, March 15, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of...


Feb 25, 2016, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Tobramycin Inhalation Solution, a Generic of (Pr)Tobi®

TORONTO, Feb. 25, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of PrTobi®....


Jan 06, 2016, 11:41 ET Teva Canada Announces the Launch of (Pr)Teva-Tolterodine Tablets and (Pr)Teva-Tolterodine LA Extended Release Capsules, Generics of (Pr)Detrol® and (Pr)Detrol LA®

TORONTO, Jan. 6, 2016 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic versions of PrDetrol® ...


Nov 17, 2015, 10:38 ET Teva Canada Announces the Launch of (Pr)Teva-Pantoprazole Magnesium, a generic of (Pr)Tecta®

TORONTO, Nov. 17, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of PrTecta®. ...


Nov 10, 2015, 08:00 ET Teva Canada Announces the Launch of (Pr)Teva-Moxifloxacin Tablet, a generic of (Pr)Avelox®

TORONTO, Nov. 10, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for a generic version of PrAvelox®...


Aug 27, 2015, 08:00 ET Teva Canada Announces the Launch of (Pr)Teva-Solifenacin, a generic of (Pr)Vesicare®

TORONTO, Aug. 27, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced Health Canada's approval of its application for the generic version of PrVesicare®...


Mar 30, 2015, 14:04 ET Teva Canada Announces the Launch of (Pr)Bortezomib for Injection, a generic of (Pr)Velcade®

TORONTO, March 30, 2015 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced that Health Canada has approved its application for the generic version of...


Dec 09, 2014, 09:00 ET Teva Canada Announces the Launch of (Pr)Teva-Erlotinib, a generic of (Pr)Tarceva®

TORONTO, Dec. 9, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Nov 18, 2014, 09:00 ET /R E P E A T -- Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex®/

TORONTO, Nov. 17, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Nov 17, 2014, 17:16 ET Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex®

TORONTO, Nov. 17, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Sep 15, 2014, 14:14 ET Teva Canada Announces the Launch of (Pr)Teva-Ezetimibe, a Generic of (Pr)Ezetrol®

TORONTO, Sept. 15, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Sep 10, 2014, 14:22 ET Teva Canada Announces the Launch of (Pr)Teva-Escitalopram, a Generic of (Pr)Cipralex®

TORONTO, Sept. 10, 2014 /CNW/ - Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of...


Dec 18, 2013, 17:00 ET PUBLIC COMMUNICATION - Health Canada Endorsed Important Safety Information on METHOTREXATE SODIUM INJECTION 25 mg/mL (2mL) - DIN 02099705 Lots 12J30KK, 12J30KH, 12J30KB

TORONTO, Dec. 18, 2013 /CNW/ - Subject: Recall of METHOTREXATE SODIUM INJECTION 25 mg/mL (2mL) DIN 02099705 - Distributed by Teva Canada Limited (formerly Novopharm Limited) Lots 12J30KK, 12J30KH,...


Nov 08, 2012, 11:14 ET Supreme Court Ruling Paves the Way for Generic Version of Viagra® - Teva Canada to Sell Sildenafil Tablets in Canada

Decision will result in increased access and significant cost savings for Canadian consumers TORONTO, Nov. 8, 2012 /CNW/ - Today's decision by the Supreme Court of Canada paves the way for...


Aug 01, 2012, 16:10 ET Teva Canada Completes Sale of Mirabel (Quebec) Facility to Halo Pharmaceutical

- Canadian Production Capacity & Jobs Maintained - - Opportunity for Growth in US and International Markets - TORONTO, Aug. 1, 2012 /CNW/ - Teva Canada and Halo Pharmaceutical announced today that...


Mar 28, 2012, 15:00 ET Teva Canada Announces Sale of Mirabel (Quebec) Facility to Halo Pharmaceutical

- Jobs and manufacturing capacity to remain in Quebec - TORONTO, March 28, 2012 /CNW/ - Teva Canada announced today that it has finalized an agreement under which Halo Pharmaceutical, a contract...


Jun 25, 2010, 16:30 ET Bayer Inc. Signs Adalat(R) XL(R) Agreement with Teva Canada Limited

TORONTO, June 25 /CNW/ - Bayer Inc. and Teva Canada Limited today announced they have entered an agreement regarding Bayer's Adalat(R) XL(R) (nifedipine) 20, 30 and 60 mg product. Effective...


Mar 10, 2010, 08:30 ET PUBLIC COMMUNICATION - Health Canada Endorsed Important Safety Information on
Fentanyl Transdermal Systems (Patches)

SUBJECT: New Changes to the Dosage Guidelines for Fentanyl Transdermal Systems (Patches) TORONTO, March 10 /CNW/ - The manufacturers of Fentanyl Transdermal Systems, in collaboration with Health...